- Case report
- Open Access
Radiation induced angiosarcoma a sequela of radiotherapy for breast cancer following conservative surgery
© Tahir et al; licensee BioMed Central Ltd. 2006
- Received: 12 July 2006
- Accepted: 11 September 2006
- Published: 11 September 2006
Radiation induced angiosarcomas (RIA) can affect breast cancer patients who had radiotherapy following conservative breast surgery. They are very rare tumors and often their diagnosis is delayed due to their benign appearance and difficulty in differentiation from radiation induced skin changes. Therefore it is very important that clinicians are aware of their existence. We report here a case of RIA followed by discussion and review of literature.
- Hyperfractionated Radiotherapy
- Benign Appearance
- Axillary Node Clearance
Angiosarcomas are rare tumors of endovascular origin. Primary angiosarcomas account for only 0.04% of breast tumors. It affects a younger age group of 20–40 yrs. Secondary angiosarcoma can be induced by radiotherapy. Cases of radiation induced angiosarcoma (RIA) have been reported in women who had radiotherapy for breast cancer. RIA occurs in an older age group, with a mean age of 68 years . It is difficult to diagnose due to its rarity, benign appearance and difficulty in differentiation from radiation induced changes in the skin .
We report a case of Angiosarcoma in a 78 years old woman. She had radiotherapy for breast cancer following conservative surgery and axillary node clearance.
In April 1996 this 78-year-old woman was diagnosed with a poorly differentiated lobular carcinoma in the upper outer part of the left breast. Clinically it measured 15 mm. She was treated with conservative breast surgery and level III axillary node clearance. Tumor margins were clear and all lymph nodes were negative. Tamoxifen was commenced at 20 mg OD.
A course of postoperative radiotherapy was arranged due to breast conservation surgery. She received 46 Gy in 23 fractions over 35 days using paired glancing megavoltage fields. This treatment was completed in July 1996 and was followed by a boost to the site of excision of a further 12 Gy in 4 fractions over 7 days using 9MEV electrons. Chemotherapy was discussed but the patient did not want to pursue this option.
Staging investigations including CT chest and abdomen, CXR and bone scan none showed any evidence of metastasis. She had wide surgical excision and reconstruction with a Vertical Rectus Abdominus Myocutaneous flap (VRAM flap). She has completed her first year follow up without any recurrence.
Radiation induced sarcomas were first reported in literature in 1929 and the first case of sarcoma after radiotherapy for breast cancer was reported by Warren & Sommer in 1936. Cahan et al  described the diagnostic criteria for Radiation induced sarcomas which include a previous history of radiotherapy with a latency period of several years (5 or more), development of sarcoma within a previous irradiated field and a histologic confirmation. This criterion was modified by Arlen et al  to include tissues adjacent to the radiated field and a shorter latency period of 3–4 years. Radiation induced angiosarcomas are characterized by their aggressive nature and most are high grade tumors [7, 8]. They can develop after many years in women who have previously had radiotherapy for breast cancer.
The etiology of radiation induced angiosarcomas in the breast remains controversial. Some investigators believe that many of the reported cases are actually metaplastic variants of the original Cancer [9, 10]. Radiation induced metaplastic transformation is thought to be related to irreversible DNA damage . Immunohistochemical stains of tumor tissue for factor VIII – related antigen & Ulex lectin stains are required to confirm the diagnosis of angiosarcoma and to differentiate it from the metaplastic recurrent breast cancer [7, 8]. In our case we have performed these tests to confirm the diagnosis.
Most cases of RIA occur in association with a total radiation dose in the range of 40–50 Gy [8, 12]. It is difficult to analyze the relationship between the total radiation dose, individual fraction dose and the incidence of RIA, due to the rarity of cases in the literature and the difficulty in retrieving information many years after the primary treatment. A minimum total dose of 10 Gy in conventional doses per fraction appears necessary to result in RIA [13, 14].
The presentation of RIA is often a cutaneous or subcutaneous lesion, painless, flat or nodular, bluish or purplish similar to benign angiomas, small hematomas or atypical telangiectasis [20, 21]. Its diagnosis is often delayed by 8–12 months [8, 11] due to a lack of specific symptoms and low suspicion following a long latency period after diagnosis of original tumor. Additional reasons cited for delayed diagnosis include difficulty in detecting the tumor in previously irradiated tissue and inadequate biopsies .
A high index of suspicion, careful patient evaluation and adequate biopsy tissue for pathologic diagnosis is mandatory. Mammography is typically negative in these cases  and diagnosis can be confirmed only by histopathological study of the biopsy. Cytology is generally misleading and not very informative .
There is general consensus in literature that the only logical treatment of RIA regardless of histologic type is wide surgical resection i.e. Mastectomy usually with a latissimus dorsi flap reconstruction. Conservative treatment even with negative margins exposes the patient to early recurrences and metastatic spread [2, 17–20, 22].
Adjuvant Chemotherapy in RIA has so far produced disappointing results .
Radiation therapy has been avoided in these cases secondary to concerns about the toxicity of repeated treatment. However recently some encouraging results have been achieved with the use of hyperfractionated radiotherapy .
This lesion is still rare, but with the increase in conservative breast surgery and radiotherapy, the incidence of RIA is likely to increase. Due to benign looking nature of the tumor in initial stages only a high index of suspicion and generous tissue biopsy can lead to early diagnosis. From review of the literature it is evident that early diagnosis and aggressive surgical approach can lead to a better prognosis. Chemotherapy has yet achieved no role in the treatment of these tumors but recently some encouraging results are seen with the use of Hyperfractionated radiotherapy and further work needs to be done in this regards.
The pictures have also been submitted to "The Breast Journal Image section" for publication.
- Stokkel MP, Peterse HL: Angiosarcoma of the breast after lumpectomy and radiation therapy for adenocarcinoma. Cancer. 1992, 69: 2965-2968. 10.1002/1097-0142(19920615)69:12<2965::AID-CNCR2820691216>3.0.CO;2-H.View ArticlePubMedGoogle Scholar
- Bolin DJ, Lukas GM: Low-grade dermal angiosarcoma of the breast following radiotherapy. Am Surg. 1996, 62 (8): 668-72.PubMedGoogle Scholar
- Martland HS: Occupational poisoning in manufacture of luminous watch dials. JAMA. 1929, 92: 466-473.View ArticleGoogle Scholar
- Warren S, Sommer GN: Fibrosarcoma of the soft parts withspecial reference to recurrence and metastasis. Arch Surg. 1936, 33: 425-450.View ArticleGoogle Scholar
- Cahan WG, Woodward HQ, Higinbotham NL, et al: Sarcoma arising in irradiated bone: report of eleven cases. Cancer. 1948, 1: 3-29. 10.1002/1097-0142(194805)1:1<3::AID-CNCR2820010103>3.0.CO;2-7.View ArticlePubMedGoogle Scholar
- Arlen M, Higinbotham NL, Huvos AG, et al: Radiation induced sarcoma of bone. Cancer. 1971, 28: 1087-1099. 10.1002/1097-0142(1971)28:5<1087::AID-CNCR2820280502>3.0.CO;2-F.View ArticlePubMedGoogle Scholar
- Brady MS, Garfein CF, Petrek JA, et al: Post-treatment sarcoma in breast cancer patients. Ann Surg Oncol. 1994, 1: 66-72. 10.1007/BF02303543.View ArticlePubMedGoogle Scholar
- Souba WW, McKenna RJ, Meis J, et al: Radiation induced sarcomas of the chest wall. Cancer. 1986, 57: 610-615. 10.1002/1097-0142(19860201)57:3<610::AID-CNCR2820570336>3.0.CO;2-P.View ArticlePubMedGoogle Scholar
- Salm R: The nature of so called post mastectomy lymphangiosarcoma. J Pathol Bacteriol. 1963, 85: 445-456. 10.1002/path.1700850225.View ArticlePubMedGoogle Scholar
- Schafler K, McKenzie CG, Salm R: Post mastectomy lymphangiosarcoma: a reappraisal of the concept – a critical review and report of an illustrative case. Histopathology. 1979, 3: 131-152.View ArticlePubMedGoogle Scholar
- Little JB: Cancer etiology: ionizing radiation. Cancer Medicine. Edited by: Holland J, Frei E III, BAst RC. 1997, Baltimore, Md: Williams & Wilkins, 293-306. 4Google Scholar
- Pitcher ME, Davidson TI, Fisher C, et al: Post irradtion sarcoma of soft tissue and bone. Eur J Surg Oncol. 1994, 20: 63-56.Google Scholar
- Tucker MA, D Angio GJ, Boice JD, et al: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987, 317: 588-593.View ArticlePubMedGoogle Scholar
- Woodard HQ: Radiation Carcinogenesis in man: a critical review. Environmental measurements lab, 380. 1980, New York. NY: US Dept of EnergyGoogle Scholar
- Strobbe LJ, Peterse HL, van Tinteren H, Wijnmaalen A, Rutgers EJTh: Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforeseen sequela. Breast cancer Res Treat. 1998, 47: 101-109. 10.1023/A:1005997017102.View ArticlePubMedGoogle Scholar
- Marchal C, Weber B, de Lafontan B, et al: Nine breast Angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive cancer centers. Int J Radiat Oncol Biol Phys. 1999, 441: 113-119. 10.1016/S0360-3016(98)00537-9.View ArticleGoogle Scholar
- Givens SS, Ellerbrock NA, et al: Angiosarcoma arising in an irradiated breast. A case review of the literature. Cancer. 1989, 64: 2214-16. 10.1002/1097-0142(19891201)64:11<2214::AID-CNCR2820641105>3.0.CO;2-E.View ArticlePubMedGoogle Scholar
- Hunter TB, Martin PC, et al: Angiosarcoma of the breast. Two case reports and a review of the literature. Cancer. 1985, 56: 2099-106. 10.1002/1097-0142(19851015)56:8<2099::AID-CNCR2820560836>3.0.CO;2-K.View ArticlePubMedGoogle Scholar
- Fineberg S, Rosen PP: Cutaneous Angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast irradiation. Am J Clin Pathol. 1994, 102: 757-63.PubMedGoogle Scholar
- Wijinmaalen A, Van Ooijen B, Van Geel BN, et al: Angiosarcoma of breast following Lumpectomy, axillary node dissection and radiotherapy for primary breast cancer: three case reports and a review of the literature. Int J Rad Oncol Biol Phys. 1993, 26: 135-9.View ArticleGoogle Scholar
- Rainwater LM, Martin JK, et al: Angiosarcoma of the breast. Arch Surg. 1986, 121: 699-72.View ArticleGoogle Scholar
- Slotman BJ, Van Hattum A, et al: Angiosarcoma of the breast following conservative treatment for breast cancer. Eur J Cancer. 1994, 30: 416-7. 10.1016/0959-8049(94)90274-7.View ArticleGoogle Scholar
- Steven J, Feigenberg , et al: Angiosarcoma after breast-conserving therapy: Experience with Hyperfractionated radiotherapy. Int J Rad Oncol Biol Phys. 2002, 52: 620-626. 10.1016/S0360-3016(01)02669-4.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.